LRRC32 and neoplasm: Complete elucidation of the GARP/GARP-ligand signaling system in Treg cells and platelets is an important challenge and a prerequisite for the future development of strategies and tools for inducing or inhibiting Treg cells in chronic infection, tumor immunotherapy, autoimmune diseases, and transplantation.